Back to Agenda
How to Accelerate Utilization of Decentralized Clinical Trial: What are issues to perform Decentralized Clinical Trial?
Session Chair(s)
Representative Invited
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Share the gap of Decentralized Clinical Trial (DCT) regulation in the EU, US and Japan. The speakers also touch how to overcome them. The session is helpful for sponsor which plan the trials.
Learning Objective : Explain DCT regulations in Japan, the US, and Europe and how to overcome their differences.
Have an account?